Saxenda

Saxenda (liraglutide) is a prescription-only injectable medication approved by the MHRA for chronic weight management in adults. It mimics the GLP-1 hormone, helping to regulate appetite and promote feelings of fullness. Saxenda is designed for adults with a BMI of 27 or higher who have at least one weight-related health condition or those with a BMI of 30 or higher. The medication works by activating the GLP-1 receptor, which influences appetite and glucose metabolism. This helps patients achieve sustainable weight loss through appetite reduction and better blood sugar regulation. In clinical trials, patients using Saxenda lost an average of 5-10% of their body weight over a 6-month period. The treatment has demonstrated efficacy in multiple studies and is approved for use in the UK. Saxenda is available in 6mg doses, and patients begin with the 0.6mg dose, which can be gradually increased over time based on individual tolerance and response. This approach ensures a personalised weight loss plan for each patient. At UK Weight Loss, we provide comprehensive support throughout your treatment journey. Our UK-registered clinicians conduct thorough consultations, monitor progress, and adjust treatment plans as needed.